Source:http://linkedlifedata.com/resource/pubmed/id/18052238
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
26
|
pubmed:dateCreated |
2007-12-19
|
pubmed:abstractText |
Soybean cake, a byproduct obtained during the processing of soybean oil, has been shown to be a rich source of isoflavones. The objectives of this study were to use soybean cake as raw material for processing into powder and to evaluate the anti-inflammatory activity. Eleven treatments, including powders of malonylglucoside, glucoside, acetylglucoside, aglycone, ISO-1, and ISO-2, as well as genistein standard, gamma-PGA, control, normal, and PDTC, were used for evaluation. A total of 77 mice were each provided daily with tube feeding for 4 weeks at a dose of 0.3 mL of aqueous solution from each treatment, and inflammation was induced with intraperitoneal injection of 1 mg/kg of body weight lipopolysaccharide (LPS). Results showed that all of the isoflavone powders and genistein standard were effective in inhibiting LPS-induced inflammation, lowering leukocyte number in mice blood and reducing production of IL-1beta, IL-6, NO, and PGE2 in both peritoneal exudate cell supernatant and peritoneal exudate fluid. All of the isoflavone treatments failed to retard T cell proliferation; however, both ISO-1 and ISO-2 could inhibit B cell proliferation. The difference in anti-inflammatory activity was minor between any of the isoflavone treatments.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Isoflavones,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Powders,
http://linkedlifedata.com/resource/pubmed/chemical/Solutions
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-8561
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11068-79
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18052238-Animals,
pubmed-meshheading:18052238-Anti-Inflammatory Agents,
pubmed-meshheading:18052238-Female,
pubmed-meshheading:18052238-Hot Temperature,
pubmed-meshheading:18052238-Inflammation,
pubmed-meshheading:18052238-Injections, Intraperitoneal,
pubmed-meshheading:18052238-Isoflavones,
pubmed-meshheading:18052238-Leukocyte Count,
pubmed-meshheading:18052238-Lipopolysaccharides,
pubmed-meshheading:18052238-Mice,
pubmed-meshheading:18052238-Mice, Inbred BALB C,
pubmed-meshheading:18052238-Powders,
pubmed-meshheading:18052238-Solutions,
pubmed-meshheading:18052238-Soybeans
|
pubmed:year |
2007
|
pubmed:articleTitle |
Anti-inflammatory effects of isoflavone powder produced from soybean cake.
|
pubmed:affiliation |
Graduate Institute of Nutrition and Food Science, School of Medicine, College of Medicine, Fu Jen University, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|